ACE and Hypertension: Despite no difference in the prevalence of hypertension or the proportion of subjects on angiotensin receptor blocker (ARB) or angiotensin-converting enzyme inhibitor (ACEI) between the two groups, subjects with PED experienced low SBP and DBP compared to those without PED (Table 1).